MIRA Pharmaceuticals, Inc.
MIRA
$0.9389
-$0.1311-12.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.40M | -2.04M | -1.69M | -1.72M | -5.79M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -732.30K |
| Total Other Non-Cash Items | 546.80K | 269.00K | 604.80K | 500.20K | 5.77M |
| Change in Net Operating Assets | 47.90K | -67.30K | 222.60K | 168.00K | -288.40K |
| Cash from Operations | -1.81M | -1.84M | -863.90K | -1.05M | -1.04M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 2.15M |
| Total Debt Repaid | 14.50K | -14.50K | 24.30K | -24.30K | -1.01M |
| Issuance of Common Stock | 478.90K | 3.13M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.35M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 47.70K | 134.70K | -- | -19.20K |
| Cash from Financing | 493.40K | 3.16M | 159.00K | -24.30K | -230.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.31M | 1.32M | -704.90K | -1.07M | -1.27M |